1. Home
  2. ENVX vs AMLX Comparison

ENVX vs AMLX Comparison

Compare ENVX & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enovix Corporation

ENVX

Enovix Corporation

N/A

Current Price

$4.78

Market Cap

1.3B

Sector

Miscellaneous

ML Signal

N/A

Logo Amylyx Pharmaceuticals Inc.

AMLX

Amylyx Pharmaceuticals Inc.

N/A

Current Price

$13.78

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ENVX
AMLX
Founded
2006
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
ENVX
AMLX
Price
$4.78
$13.78
Analyst Decision
Buy
Strong Buy
Analyst Count
8
9
Target Price
$14.56
$19.56
AVG Volume (30 Days)
5.5M
808.9K
Earning Date
05-21-2026
06-08-2026
Dividend Yield
N/A
N/A
EPS Growth
40.94
65.46
EPS
N/A
N/A
Revenue
$31,821,000.00
$380,786,000.00
Revenue This Year
$40.85
N/A
Revenue Next Year
$236.84
N/A
P/E Ratio
N/A
N/A
Revenue Growth
37.91
1612.94
52 Week Low
$4.84
$3.11
52 Week High
$16.49
$17.49

Technical Indicators

Market Signals
Indicator
ENVX
AMLX
Relative Strength Index (RSI) 29.16 46.18
Support Level N/A $13.61
Resistance Level $8.65 $15.27
Average True Range (ATR) 0.35 0.89
MACD -0.05 -0.10
Stochastic Oscillator 5.40 11.80

Price Performance

Historical Comparison
ENVX
AMLX

About ENVX Enovix Corporation

Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, the United States, Norway, Taiwan, and other regions.

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.

Share on Social Networks: